november AG

euro adhoc: november AG
Restructuring & Recapitalisations
BAFin relieves BIOMED Beteiligungsgesellschaft and Dr. Claus Müller from submitting a mandatory offer

-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- 16.11.2007 Erlangen, 16. November 2007. November AG has been notified that BAFIN relieves BIOMED and Dr. Claus Müller from submitting a mandatory offer under section 37 of the german securities acquisitions and takeover act (wpüg) in conjunction with section 9 of the Offer regulations in case they gain control of the company. Submitting such an offer would have been mandatory if a shareholder holds at least 30% of a company's voting shares. The decision made by bafin also makes it possible to implement the decisions made on 22th may 2007 at the annual general meeting (AGM)of the company. end of announcement euro adhoc 16.11.2007 14:24:07 -------------------------------------------------------------------------------- ots Originaltext: november AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Marcus Weichert Leitung PR/IR Telefon: +49(0)9131 75088 868 E-Mail: weichert@november.de Branche: Biotechnology ISIN: DE0006762909 WKN: 676290 Index: CDAX, Technologie All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade Börse Hannover / free trade Börse München / free trade

Das könnte Sie auch interessieren: